ICP
ELV icon

Impact Capital Partners’s Elevance Health ELV Stock Holding History

Impact Capital Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,048
Closed -$408K – 276
2025
Q2 		$408K Buy
1,048
+86
+9% +$34.6K 0.13% 162
2025
Q1 		$418K Buy
962
+315
+49% +$126K 0.15% 157
2024
Q4 		$239K Buy
+647
New +$271K 0.08% 229

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Impact Capital Partners's ELV Position: Q3 2025 in Review

Impact Capital Partners sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 1,048 shares — an estimated $408K sold.

Impact Capital Partners first reported a position in ELV in Q4 2024 and held it in 3 quarters. The position peaked at $418K in Q1 2025. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Impact Capital Partners reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Impact Capital Partners sold 1,048 Elevance Health shares in Q3 2025, an estimated $408K.
  • Impact Capital Partners first reported a position in Elevance Health in Q4 2024 and held it in 3 quarters.
  • Impact Capital Partners's Elevance Health position peaked at $418K in Q1 2025.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Impact Capital Partners's 13F filing for Q3 2025, filed 28 Oct 2025.